FTase Inhibitor I (Synonyms: Farnesyltransferase Inhibitor I) |
| Katalog-Nr.GC18260 |
FTase-Inhibitor I ist ein potenter Hemmstoff der Farnesyltransferase (FTase; IC50 = 21 nM), der über 30-fach selektiver für FTase als für Geranylgeranyl-Transferase (GGTase; IC50 = 790 nM) ist.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 149759-96-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
FTase inhibitor I is a potent inhibitor of farnesyltransferase (FTase; IC50 = 21 nM) that is greater than 30-fold selective for FTase over geranylgeranyl transferase (GGTase; IC50 = 790 nM). It prevents farnesylation of Ras and inhibits proliferation of cells transformed by Ras farnesylation. In a dog model of subarachnoid hemorrhage, it reduces GTP-Ras in spastic basilar arteries, decreases angiographic vasospasm, and improves clinical scores.
Review for FTase Inhibitor I
Average Rating: 5 (Based on Reviews and 27 reference(s) in Google Scholar.)
Review for FTase Inhibitor I
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *